| Trial registration number
|
NCT05525832 |
Full text link
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05525832
|
First author
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Ioannis Pantazopoulos
|
Contact
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
2022-09-02
|
Recruitment status
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
adult patients hospitalized primarily for covid-19 pneumonia
confirmed sars-cov2 infection diagnosed through rt-pcr test of nasopharyngeal samples
|
Exclusion criteria
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
patients with confirmed sars-cov2 infection who were not primarily admitted for covid-19 pneumonia
patients with use of intranasal sprays for at least two weeks prior to study enrollment
sinonasal surgery within 3 months prior to study enrollment
patients with sinusitis
inability to perform nasopharyngeal wash
participation in other trials
|
Number of arms
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Larissa University Hospital
|
Inclusion age min
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Greece
|
Type of patients
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Moderate disease at enrollment
|
Severity scale
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
3: Moderate disease at enrollment
|
Total sample size
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
50
|
primary outcome
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
SARS-CoV2 viral load
|
Notes
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Sept. 3, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "nan", "treatment_id": 864, "treatment_name": "Nasal irrigation and gargling with saline (hsnig)", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|